FEATURED, Chemotherapy, Neoadjuvant Treatment, Research
Checkpoint Inhibitor Plus Chemotherapy Dramatically Improves Complete Response Rates Over Chemotherapy Alone in Neoadjuvant Setting
Evading the immune system is mandatory for a tumor to progress. To mount an attack on invading tumor cells, T-cells use a cell surface protein called PD-1 (PD, ...
FEATURED, Chemotherapy, Research, Fertility
Discussing Fertility with Younger Patients Facing Chemotherapy
Latest research shows possibility of ovarian preservation Approximately 50% of young patients with breast cancer are concerned about their risk of infertility a...
“Biosimilars” OK for Your Patients: Same Effectiveness. Lower Cost.
Trastuzumab Biosimilar ABP 980 Study Demonstrated Clinical Non-Inferiority Biosimilars are biologic products that are highly similar but have no clinically mean...
